New gene variant identified for advance PCa. From the Cleveland Clinic Press Release:
"This study – the first clinical trial validation of the relationship between HSD3B1 status and clinical outcomes – suggests that genetic testing for HSD3B1(1245C) may help physicians identify patients most likely to benefit from additional and more aggressive treatment . . .
Taken together, these findings suggest that the presence or absence of this genetic variant can be used to help identify men with low-volume metastatic prostate cancer most at risk for quick progression to treatment resistance and earlier death – a discovery with significant implications for clinical care and genetic counseling."
Full Press Release is here:
newsroom.clevelandclinic.or...
And the abstract and full article in JAMA Oncology is available here:
jamanetwork.com/journals/ja...
And a VERY informative 11+ minute JAMA Oncology interview with study author Nima Sharifi, M.D is here:
edhub.ama-assn.org/jn-learn...
Good Stuff (It's coming) - Be Well - K9 terror